Pharmaron Beijing Co., Ltd. (PHBBF)
Pharmaron Beijing Market Cap : 3.546B for May 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| WuXi Biologics (Cayman), Inc. | 17.57B |
| WuXi AppTec Co., Ltd. | 49.87B |
| Viva Biotech Holdings | 427.92M |
| Genscript Biotech Corp. | 3.769B |
| Austar Lifesciences Ltd. | 35.88M |
Market Cap Related Metrics
| PE Ratio | 14.40 |
| PS Ratio | 1.673 |
| Price to Book Value | 1.488 |
| Price to Free Cash Flow | 66.97 |
| Price | 1.93 |
| Earnings Yield | 6.94% |
| Operating PE Ratio | 11.68 |
| Normalized PE Ratio | 14.83 |